Get the latest insights on issues impacting mergers and acquisitions from RBC Capital Markets' investment banking team.
Perspectives from the cutting edge of biotech and pharma
Our serialized podcast series delivers highly differentiated insights and intelligence, turning today’s faster-moving trends into tomorrow’s opportunities
Fresh perspective and nuanced, data driven view of the forces shaping U.S. equity markets
Macro and market strategy series – explores the latest financial market and economic developments
Search all podcasts:
Insights
July 2024
In today's podcast, we discuss extreme investor sentiment, earnings season and a durable leadership shift, high...
Markets in Motion
In today's podcast, we discuss how we see 2Q24 reporting season as a key test for the rotation trade that attempted to...
Pathfinders in Biopharma
Ronald Martell is a serial entrepreneur and biopharma veteran whose record includes the launch of Herceptin. He...
RBC Global Energy’s Nick Woodruff and Tim Perry discuss the trends shaping the landscape of commodities, energy, and...
With a combined deal value of $29bn under their belts this year, four CEOs reflect on what they’ve learned from...
As biotech investment reignites, how are venture capitalists responding? Noël Brown, Head of U.S. Biotechnology...
In this episode, we discuss why we are lifting our YE 2024 S&P 500 price target to 5,700 from 5,300, which we would...
June 2024
In today's podcast, we discuss how the Duke CFO survey highlights how C-Suite confidence has remained steady, with...
RBC’s Markets in Motion is the weekly podcast from Lori Calvasina, Head of US Equity Strategy at RBC Capital Markets...
Get the latest insights from RBC Capital Markets delivered to your inbox.